Skip to content

Risk Minimisation Materials

Search for Risk Minimisation Materials...

You can search the eMC for Risk Minimisation Materials (RMMs) by

  • Company
  • Common medicine name
  • Title of Risk Minimisation Material

List all materials for medicines starting with:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Result: Risk Minimisation Materials for medicines starting with the letter X

Certain risk materials on this website are intended for use by healthcare professionals only.

By proceeding you are confirming that you are a healthcare professional.

Want to avoid this message? If you are a Healthcare professional, REGISTER or LOGIN and you will not have to self-certify when you access Risk Minimisation Materials.

Xarelto

Bayer plc

Xarelto Combined Patient Alert Card

Patient alert card for Xarelto 2.5mg, 15mg & 20mg.

Xarelto Prescriber Guide

Xarelto Prescriber Guide

For Healthcare Professionals

Xeljanz

Pfizer Limited

Xeljanz (tofacitinib) Healthcare Professional Brochure

Prescriber brochure to provide guidance on assessments prior to prescribing, management, monitoring and safety considerations related to the Risk Management Plan.

For Healthcare Professionals

Xeljanz (tofacitinib) Initiation Checklist

Prescriber Initiation checklist to remind HCPs of the risks associated with the use of tofacitinib and the recommended tests before and during tofacitinib administration and treatment

For Healthcare Professionals

Xeljanz (tofacitinib) Maintenance Checklist

Prescriber Maintenance checklist to remind HCPs of the risks associated with the use of tofacitinib and the recommended tests before and during tofacitinib administration and treatment

For Healthcare Professionals

Xeljanz (tofacitinib)Patient Alert Card

Patient alert card to help patients understand the risks associated with XELJANZ, and remind them to seek immediate medical attention if they experience any listed signs and symptoms.

For Healthcare Professionals

Xgeva

Amgen Ltd

XGEVA patient reminder card

This reminder card contains important safety information that patients need to be aware of before and during treatment with denosumab (XGEVA) injections for cancer-related conditions,
A side effect called osteonecrosis of the jaw (ONJ, bone damage in the jaw) has been reported commonly (may affect up to 1 in 10 people) in patients receiving XGEVA injections for cancer-related conditions. ONJ can also occur after stopping treatment.
It is important to try to prevent ONJ developing as it may be a painful condition that can be difficult to treat. In order to reduce the risk of developing ONJ, there are some precautions patients should take.
To request a copy of the patient card, please contact Amgen Medical Information on +44 (0) 1223 436441

Xiapex

Swedish Orphan Biovitrum Ltd

Xiapex Injection Training Brochure

Xiapex Injection Training Brochure for Dupuytren’s Contracture. For Healthcare Professionals

For Healthcare Professionals

Xiapex Training Brochure for Peyronie's Disease

Xiapex injection training Brochure for Peyronie's Disease. For Healthcare Professionals

For Healthcare Professionals

Xomolix

Kyowa Kirin Ltd

Xomolix Prescriber Guide

Xomolix (droperidol 2.5mg/ml) solution for injection - Important risk minimisation information for healthcare professionals

For Healthcare Professionals

Xyrem

UCB Pharma Limited

Initiation Checklist and follow up visit form for Xyrem

Important risk minimisation information for healthcare professionals: Treatment initiation and follow-up visit form

For Healthcare Professionals

Risk minimisation information for Xyrem

Important risk minimisation information for patients: frequently asked questions (FAQ) Information sheet

Step by Step Instruction Guide: Xyrem

Important risk minimisation information for patients on how to take Xyrem.

Xyrem Alert card

Important safety information for patients and physicians/pharmacists.

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue